文献速递产科母胎医学

子痫前期病史女性再次妊娠的母儿结局及复发危险因素分析

[Analysis of maternal and fetal outcomes and related factors of recurrence in women with a history of pre-eclampsia].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2026-01-01

该研究纳入176例有子痫前期史的单胎妊娠孕妇,按本次妊娠结局分为正常妊娠组92例和复发组84例,复发组中再次子痫前期45例、妊娠期高血压39例。结果显示,复发组孕前BMI更高、新生儿出生体重更低、胎儿生长受限发生率更高。多因素logistic回归提示,本次妊娠孕前BMI是妊娠期高血压疾病复发的独立危险因素。

要点

  • 有子痫前期史的孕妇再次妊娠易复发妊娠期高血压疾病,应重视孕前体重管理。
  • 复发组胎儿生长受限发生率显著高于正常妊娠组,孕期需加强胎儿生长监测。
  • 孕前BMI每增加1个单位,复发风险升高约12%(OR=1.12)。

核心结论

  • 有子痫前期史的孕妇再次妊娠时易再次发生妊娠期高血压疾病。
  • 控制孕前BMI可显著降低妊娠期高血压疾病复发率。

研究设计与样本

  • 单中心回顾性研究,纳入2020年1月至2024年12月于首都医科大学附属北京妇产医院规律产检并住院分娩的有子痫前期史的单胎妊娠孕妇176例。
  • 按本次妊娠结局分为正常妊娠组92例和复发组84例,复发组包括再次子痫前期45例和妊娠期高血压39例。
  • 采用多因素logistic回归分析有子痫前期史孕妇再次发生妊娠期高血压疾病的影响因素。

主要发现

  • 两组前次妊娠中孕周≥28周、早发子痫前期、重度子痫前期、HELLP综合征、分娩方式、新生儿存活率及胎儿生长受限发生率比较,差异均无统计学意义(P均>0.05)。
  • 正常妊娠组孕前BMI为(23.0±3.8)kg/m2,显著低于复发组的(25.6±4.7)kg/m2(P=0.014)。
  • 正常妊娠组新生儿出生体重为(3 280±586)g,显著高于复发组的(3 020±700)g(P=0.010)。
  • 正常妊娠组胎儿生长受限发生率为5.4%(5/92),显著低于复发组的19.0%(16/84)(P=0.005)。
  • 两组分娩方式、分娩孕周、足月产率、新生儿与前次妊娠同性别、新生儿窒息、胎盘早剥及产后出血发生率比较,差异均无统计学意义(P均>0.05)。

关键数值与推荐

  • 调整既往子痫前期发病孕周、早发子痫前期、重度子痫前期、HELLP综合征、孕妇年龄、妊娠期增重、分娩间隔、受孕方式、使用低剂量阿司匹林及妊娠期糖尿病后,本次妊娠孕前BMI是妊娠期高血压疾病复发的独立危险因素(OR=1.12,95%CI为1.03~1.22;P=0.008)。

临床怎么用

  • 有子痫前期史的备孕女性应提前控制孕前BMI以降低再次发生妊娠期高血压疾病的风险。
  • 再次妊娠期间应加强对胎儿生长受限的筛查与监测。

局限性

  • 原文提到使用小计量阿司匹林,未报告该干预的具体剂量与使用方案。
  • 原文未报告研究总体样本量计算依据及缺失数据情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the maternal and neonatal outcomes of women with a history of pre-eclampsia (PE) and the risk factors for recurrence. Methods: A total of 176 singleton pregnant women with a history of PE who received regular prenatal examination and hospitalized for delivery in Beijing Obstetrics and Gynecology Hospital, Capital Medical University from January 2020 to December 2024 were collected. According to the pregnancy outcome, they were divided into normal pregnancy group (92 cases) and recurrent pregnancy group (84 cases, including 45 cases of recurrent PE and 39 cases of gestational hypertension). The previous pregnancy, general condition and pregnancy outcomes of the current pregnancy were compared between the two groups. Multivariate logistic regression was used to analyze the influencing factors of hypertensive disorder in pregnancy in pregnant women with a history of PE. Results: (1) Previous pregnancy: there were no significant differences in the incidence of gestational age≥28 weeks, early onset PE, severe PE, hemolysis, elevated liver enzymes, and low platelet count syndrome (HELLP syndrome), delivery mode in the previous pregnancy, neonatal survival rate and fetal growth restriction between the normal pregnancy group and the recurrent pregnancy group (all P>0.05). (2) The current pregnancy: the pre-pregnancy body mass index (BMI) of the normal pregnancy group was significantly lower than that of the recurrent pregnancy group [(23.0±3.8) vs (25.6±4.7) kg/m2, P=0.014], and there were no significant differences in other general data between the two groups (all P>0.05). The neonatal birth weight in the normal pregnancy group was significantly higher than that in the recurrent pregnancy group [(3 280±586) vs (3 020±700) g, P=0.010], and the incidence of fetal growth restriction was significantly lower than that in the recurrent pregnancy group [5.4% (5/92) vs 19.0% (16/84), P=0.005]. However, there were no significant differences in the mode of delivery, gestational age at delivery, full-term delivery rate, the same gender as the previous pregnancy, neonatal asphyxia, placental abruption, and postpartum hemorrhage between the two groups (all P>0.05). (3) Multivariate analysis: after adjusting the confounding factors, including previous gestational age of PE onset, previous early onset PE, previous severe PE, previous HELLP syndrome, maternal age, weight gain during pregnancy, delivery interval, mode of conception, use of low-dose aspirin, and gestational diabetes mellitus, the results showed that pre-pregnancy BMI was an independent risk factor for recurrence of hypertensive disorders in pregnancy (OR=1.12, 95%CI: 1.03-1.22; P=0.008). Conclusions: Women with a history of PE are prone to develop hypertensive disorders in pregnancy again. Controlling pre-pregnancy BMI could significantly reduce the recurrence rate. Attention should be paid to the occurrence of fetal growth restriction during pregnancy. 目的: 探讨子痫前期(PE)病史孕妇再次妊娠的母儿结局及复发相关因素。 方法: 收集2020年1月至2024年12月于首都医科大学附属北京妇产医院规律产前检查并住院分娩的有PE史的单胎妊娠孕妇176例,按照妊娠结局分为正常妊娠组(92例)和复发组(84例,其中再次发生PE 45例、妊娠期高血压39例),比较两组的前次妊娠情况、本次妊娠的一般情况及妊娠结局,采用多因素logistic回归分析PE史孕妇再次发生妊娠期高血压疾病的影响因素。 结果: (1)前次妊娠情况:正常妊娠组与复发组孕妇前次PE发病孕周≥28周、早发PE、重度PE、溶血、肝酶升高和低血小板计数综合征(HELLP综合征)的发生率、前次妊娠分娩方式、新生儿存活率、胎儿生长受限发生率分别比较,差异均无统计学意义(P均>0.05)。(2)本次妊娠情况:正常妊娠组孕妇的孕前体重指数(BMI)显著低于复发组[分别为(23.0±3.8)、(25.6±4.7)kg/m2,P=0.014],其他一般资料两组比较,差异均无统计学意义(P均>0.05)。正常妊娠组的新生儿出生体重显著高于复发组[分别为(3 280±586)、(3 020±700)g,P=0.010],胎儿生长受限发生率显著低于复发组[分别为5.4%(5/92)、19.0%(16/84),P=0.005],但两组孕妇的分娩方式、分娩孕周、足月产率、新生儿与前次妊娠同性别、新生儿窒息、胎盘早剥、产后出血的发生率分别比较,差异均无统计学意义(P均>0.05)。(3)多因素分析:调整混杂因素既往PE发病孕周、既往早发PE、既往重度PE、既往HELLP综合征、孕妇年龄、妊娠期增重、分娩间隔、受孕方式、使用小计量阿司匹林、妊娠期糖尿病后结果显示,本次妊娠孕前BMI是妊娠期高血压疾病复发的独立危险因素(OR=1.12,95%CI为1.03~1.22;P=0.008)。 结论: PE史孕妇再次妊娠时易再次发生妊娠期高血压疾病,控制孕前BMI可显著降低复发率,妊娠期应关注胎儿生长受限的发生。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang, Zhang, Wu, et al. [Analysis of maternal and fetal outcomes and related factors of recurrence in women with a history of pre-eclampsia]. Zhonghua Fu Chan Ke Za Zhi. 2026. PMID: 41765649. doi:10.3760/cma.j.cn112141-20250820-00388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。